Objective: In 2012, 7 years after the introduction of antiretroviral treatment (ART) in the South African township of Orange Farm, we measured the proportion of HIV-positive people who were virally suppressed, especially among high-risk groups (women 18-29 years and men 25-34 years).
Introduction
Antiretroviral treatment (ART) has been rapidly scaled-up in sub-Saharan Africa in the last decade. It was initially used to prevent HIV-related deaths, as well as for the prevention of mother-to-child transmission (PMTCT) [1, 2] . More recently, different studies highlighted the preventive effect of ART on onward sexual transmission [3] [4] [5] , which has led the WHO to recommend the use of ART for both individual and collective benefits [6] . However, to have an impact on HIV incidence at a population level, the coverage of those receiving treatment and having a suppressed viral load (as a proportion of all people living with HIV) should be high [7, 8] . Particularly, ART coverage and viral suppression should be high among the age groups representing the highest HIV incidence levels. Recently, the Joint United Nations Programme on HIV/AIDS (UNAIDS) proposed ambitious treatment targets for 2020, suggesting that 90% of all HIV-infected people should be diagnosed by 2020, 90% of all HIVdiagnosed people should be receiving sustained ART and 90% of people receiving ART should be virally suppressed [9] . Meeting this '90-90-90'target would result in viral load suppression among 73% of all people living with HIV, and would contribute significantly to the reduction of new infections and AIDS-related deaths and the UNAIDS goal of ending the AIDS epidemic by 2030.
Information documented to date highlights many failures along the so-called cascade of HIV care, with suboptimal efficiency of HIV testing, linkage to HIV care, ART initiation and viral suppression [10] [11] [12] . Estimating the overall proportion of viral suppression and identifying failures along the cascade of care in specific settings is a starting point for strategically planning the way forward toward reaching the UNAIDS 2020 targets and for identifying ways to improve ART program efficiency. Moreover, the majority of the studies published to date are clinic based and thus did not provide insight into those not linked or retained in care [13] .
Relying on a representative sample of the adult population from a South African hyper-endemic periurban setting, where an intensified HIV prevention program has been conducted since 2008, our main objective was to estimate the proportion of HIV-infected adults with viral suppression, especially among the highly exposed age groups. The secondary objectives were to document completion of each step of HIV cascade and to identify factors associated with their successful completion and to assess the effectiveness of the ART program in preventing AIDSrelated deaths between 2005 and 2012.
Methods

Study community
The study was conducted in the township of Orange Farm, located approximately 40 km from Johannesburg, South Africa. The adult population is estimated at around 110 000. The township is located in a district with one of the most severe HIV epidemics in the world, with HIV prevalence estimated at 30% among women attending antenatal clinics in 2011 [14] . ART became available in 2004 in the community, but was only available throughout all Orange Farm clinics in 2005. This later date was retained as the starting date of the ART program for the purpose of our study. Orange Farm was the setting of the first randomized controlled trial on voluntary male medical circumcision (VMMC), conducted between 2002 and 2004 [15] , and of an intensified VMMC scaleup program conducted since 2008 [16] . This program includes community mobilization and free VMMC. In the clinics offering VMMC, free HIV counseling and testing (HCT) are also offered.
Survey
We used a one-stage self-weighting sampling design to select a representative random sample of households in the community. Between January and December 2012, every adult aged 18 years or older and having slept at least two nights in the selected households during the previous seven nights was invited to participate in the study. Informed consent was obtained from all participants, interviews were conducted using standardized questionnaires, a genital examination was performed and blood samples were collected at the study site. The following information was collected through standardized questionnaires: age, ethnic group, marriage history, occupation, education level, alcohol consumption, age at sexual debut, lifetime number of sexual partners, condom use at last sexual intercourse, HIV testing history (ever/ never tested and date of the first HIV test) and, among women, pregnancy history. Among men, a genital examination was performed to determine male circumcision status. The date of circumcision was also collected.
Laboratory procedure
Each participant was invited to supply a venous blood sample. Samples were collected in plasma preparation tubes and centrifuged. A screening test for HIV (Genscreen HIV1/2 version 2; Bio-Rad, Marnes-la-Coquette, France) was performed on all plasma samples. For reactive samples, a confirmatory test was run (Vironostika, HIV Uni-Form II plus O; bioMérieux, Boxtel, The Netherlands). If the sample reacted positively for both assays, a second confirmatory test was conducted (Murex HIV-1.2.O; Murex Biotech Ltd., Dartford, UK). Plasma samples testing positive for HIV were also tested for the presence of the most common antiretroviral drugs currently in use in South Africa (lamivudine, stavudine, zidovudine, nevirapine, efavirenz, ritonavir, lopinavir, emtricitabine, tenofovir, abacavir and atazanavir) using ultra performance liquid chromatography coupled with tandem mass spectrometry according to a slightly modified previously published method [17] . Plasma HIV-1 RNA load was determined by reverse-transcription PCR using an assay designed to detect all M-group subtypes (Amplicor HIV-1 Monitor Test V1.5; Roche Diagnostic System Ins., Branchburg, New Jersey, USA) [18] .
Ethics
Ethical clearance for the surveys was granted by the Human Research Ethics Committee (Medical) of the University of the Witwatersrand on 8 May 2007 (M070367).
Outcomes
In addition to the HIV status of participants, our outcomes included the successive steps of the cascade of HIV care, defined as having been ever tested for HIV, testing positive for the use of any antiretroviral drugs and having viral suppression, defined as viral load less than 400 copies/ml (alternative thresholds were also used: <50 or <1000 copies/ml). We also calculated the ratio of antiretroviral-positive people over those HIV-negative. At the community level, we calculated the detectable viral load proportion, defined as the proportion of untreated or treated but not virally suppressed HIV-infected people, and as such representing the fraction of the population potentially exposing their sexual partners to HIV [13, 19] .
For participants testing positive for the use of antiretroviral drugs, the ART profile was categorized as definite/probable/possible first-line regimen, definite/ probable/possible second-line regimen or undetermined (see Table S1 , Supplemental Digital Content 1, http:// links.lww.com/QAD/A932, which describes the ART profiles).
Statistical analysis
For each outcome, we calculate the percentage and 95% confidence interval (CI). For HIV-positivity and the different steps of the treatment cascade, we identified associated factors through univariate and multivariate Poisson regression, which allowed the calculation of unadjusted and adjusted prevalence rate ratio (respectively, PRR and aPRR) [20] . Variables considered in the multivariate models included all covariates associated with the studied outcome with a P value less than 0.2 in univariate analysis.
We conducted additional analyses restricted to the highly exposed age groups, defined as those age groups with a particularly high HIV incidence rate, including 18-29year-old women and 25-34-year-old men [21] . The outcomes were also studied in the subpopulation of women reporting having been pregnant during the past 12 months.
The number of participants testing positive for antiretroviral drugs was expressed as a ratio relative to the number of HIV-negative participants in the sample (number nondirectly dependent on ART programs). Using a basic model (see Text, Supplemental Digital Content 2, http://links.lww.com/QAD/A932, which describes the model), we estimated what this ratio would have been if every HIV-infected person in the community had received ART using the treatment threshold of CD4 þ cell count less than 200 cells/ml (which since 2005, has corresponded to the 2006 WHO guidelines [2] ). This model assumed a stable population and a stable HIV epidemic (i.e. HIV incidence roughly equals AIDS-related mortality).
Analyses were performed using the statistical software R [22] .
Results
Sample characteristics A total of 3293 men and 3473 women participated in the study. The overall participation rate was 60%. HIV prevalence and factors associated with HIVpositivity HIV prevalence was 17.0% [15.7-18 .3%] among men and 30.1% [28.5-31 .6%] among women (overall: 23.7% [22.7-24.7%]). Age-specific HIV prevalence is presented in Fig. 1 . Results of the risk factor analysis of HIVpositivity are presented in a table (see Table S2 , Supplemental Digital Content 3, http://links.lww.com/QAD/A932, which describes the data).
Uptake of HIV testing
Overall, 59.1% [57.4-60.8%] of men and 79.5% [78. .9%] of women reported having been previously tested for HIV. These proportions were 65.7% [62.5-68.7%] and 84.2% [82. .0%], respectively, among the highly exposed age groups.
Among men, independent predictors of lifetime uptake of HIV testing were having ever been married, being at school, being HIV-positive and being circumcised ( Table 2 ). This latter factor was the strongest predictor of having ever been tested. Among circumcised men, 23 Factors associated with the use of antiretroviral drugs among both sexes were age and condom use during their last sexual encounter (Table 3 ). In addition, being unemployed (vs employed) among men and having a low alcohol consumption among women were independently associated with antiretroviral-positivity. Male circumcision status was not associated with antiretroviral-positivity, whereas among women from highly exposed age groups, recent pregnancy was associated with antiretroviral-positivity (aPRR ¼ 2.08 [1.22-3.57]). In univariate analysis, none of the studied risk factors were found to be significantly associated with viral load suppression (see Table S3 , Supplemental Digital Content 4, http://links.lww.com/ QAD/A932, which describes the results of the analysis).
None of the participants with a count of viral load more than 1000 copies/ml was under a definite, probable or possible second-line ART regimen, and thus potentially in need of a third-line regimen.
Overall cascade of HIV care and viral suppression Figure 2 
Assessing the effectiveness of antiretroviral treatment programs
We calculated the ratio of people using antiretroviral drugs to those HIV-negative to be 0.084. Using the basic model (see Text, Supplemental Digital Content 2, http:// links.lww.com/QAD/A932, which describes the model), we estimated that if ART programs implemented in Orange Farm since 2005 were successful in averting every AIDS-related death, this ratio would be 0.184. By comparing the observed ratio with that calculated under the hypothesis of maximum effectiveness, we estimate the effectiveness of the ART program in preventing AIDS-related deaths to be 46%.
Discussion
In 2012, in a periurban South African community, hyperendemic for HIV, 23.7% of all HIV-infected people were virally suppressed. Furthermore, this proportion was significantly lower among age groups most exposed to HIV infection. These levels can be considered as a starting point for developing strategic plans for reaching the proposed UNAIDS target for 2020, namely to achieve viral suppression among 73% of all people living with HIV. A large majority of the population reported having been tested for HIV, whereas just over one in four people living with HIV were receiving ART. When correctly taken, ART was highly effective in achieving viral suppression. Using a basic model, we also demonstrate that ART programs conducted until 2012 have had an effectiveness of 47-67% in preventing AIDS-related deaths in this community.
The study has several limitations. We defined steps along the cascade of HIV care that differ from those suggested in relation to the proposed UNAIDS target [9] , with specific reference to the first two steps (percentage of lifetime HIV testing and proportion of those testing positive for the use of antiretroviral drugs). We cannot infer the percentage of diagnosed HIV infections from information on lifetime uptake of HIV testing. However, the percentage of HIVinfected participants reported having never been tested for HIV may be interpreted as a lower boundary of the proportion of undiagnosed HIV infections. Furthermore, the proportion of HIV-infected participants testing positive for antiretroviral drugs may underestimate the true proportion of participants having initiated ART, because participants receiving ART but not taking treatment at the time of the survey would test negative for ART. However, our third cascade indicator, the percentage of HIV-infected participants with suppressed viral load, integrates information from previous steps and is comparable with that proposed by UNAIDS. Moreover, the results of this study do not rely on longitudinal data, and thus do not allow for a comprehensive understanding of the dynamics that may affect the different steps along the HIV cascade [23] . However, the cross-sectional nature of our data presents a snapshot of the cascade of care in Orange Farm that may be representative at the community level. Moreover, as we rely on data collected from a representative sample of the population, our indicator has the advantage of being less affected by reporting or participation bias than results obtained in clinical settings [13] . Other limitations were that we have used high incidence groups as a proxy for high transmitters and the questionnaire should have included questions about date of most recent HIV test, as well as date of the first test, and some indication of how many tests there were in between.
The proportions of the population having previously been tested for HIV in our study are very similar to those documented at the national level in South Africa [21] . In particular, almost all women having recently been pregnant reported having ever been tested for HIV, which may reflect the impact of PMTCT programs [24, 25] . The level of lifetime HIV testing documented in South Africa is among the highest in sub-Saharan Africa [26] . However, in this study, at least 17 and 39% of HIVinfected women and men, respectively, did not know their HIV status, which highlights the need to strengthen HIV-testing programs. More specifically, repeat HIV testing should be promoted to allow earlier linkage to care and ART initiation [27] . Our data did not provide direct information on this issue, but results on lifetime testing suggest that the proportion of people who have been repeatedly tested is low, especially among men. Previous studies conducted in South Africa suggest that the proportion of repeat testers among HIV test users ranges from 26 to 71%, depending on the local and testing context [28] [29] [30] .
The proportion of HIV-infected people testing positive for the use of antiretroviral drugs in our study was slightly lower than that estimated in a 2012 national populationbased survey in South Africa (31.2%), with the proportion being consistently higher among women than men [21] . In 2013, in a township in the Cape Town area, Kranzer et al. [31] reported that 33.5% of all HIVinfected individuals were receiving ART. This slightly higher estimate may be explained by over-estimation due to self-reporting. The proportion of people on secondline treatment regimes in our study was close to the WHO projections for low-income and middle-income countries [32] .
The study was conducted in a community where VMMC has been intensively promoted as part of a combined HIV prevention package, including HCT, since 2008 [16] . We therefore observed a probable secondary benefit of VMMC programs: circumcised men were more likely to have ever been tested for HIV than uncircumcised men. Moreover, among circumcised men, nearly one in four reported having undergone a first HIV test as part of the VMMC procedure.
Although significant progress has been made in scaling up the provision of ART to eligible people living with HIV in sub-Saharan Africa, coverage remains suboptimal. For example, in 2009, ART coverage in South Africa, using the 2006 WHO guidelines (CD4 þ cell count <200 cells/ ml) was estimated at around 56% [33] . National-level coverage was estimated by UNAIDS using a model which is based on national epidemiological data and assumptions on average survival rates with and without ART, and average time between sero-conversion and eligibility for treatment [34] . Using a basic model and relying on the same kind of data and assumptions, we estimated that the effectiveness of ART programs was less than 50% in preventing AIDS-related deaths in the Orange Farm community between 2005 and 2012. These results highlight the need for better efficiency in every step of the cascade of HIV care, from HIV testing and diagnosis, to ART initiation, retention in care and adherence to treatment [11, 35] .
The level of viral suppression among the adult population infected with HIV in the Orange Farm community was found to be very similar to the 2013 UNAIDS estimate for sub-Saharan Africa of 24% [12] . A rough estimate of the impact of such a level of viral suppression might be obtained by comparing the detectable viral load proportion, that is the fraction of the population potentially exposing partners to HIV [13, 19] to the crude HIV prevalence in the community. This basic calculation suggests a decrease in HIV incidence of 25% due to the preventive effect of ART. However, the true preventive effect of ART may have been lower, as lower levels of viral suppression were observed in the younger age groups among whom HIV incidence is at its highest levels. At the 2012 coverage level, we therefore cannot expect ART to have had a large impact on HIV incidence in this community.
Our study shows that people receiving ART were more likely to report condom use at the last sexual encounter compared with untreated HIV-infected participants. This association may reflect the behavioral preventive effect of ART that has previously been described [36] [37] [38] [39] .
Another encouraging result from our study is that, when antiretroviral drugs are correctly taken and thus detectable in blood, their effectiveness in suppressing HIV viral load is high. Close to all treated participants presented a viral load less than 1000 copies/ml, which is the usual threshold of effective treatment. However, our results do not provide evidence to help understand why some patients interrupt or are insufficiently adherent to their treatment.
Conclusion
The study allowed the assessment of the gap between the 2012 level of viral suppression among the HIV-infected population of a hyper-endemic community in South Africa and the proposed UNAIDS treatment targets for 2020. The Orange Farm township is fairly representative of other semi-urban areas and our results may therefore be generalizable to those obtained in other sub-Saharan hyper-endemic semi-urban settings. Although good progress has been made in the last decade in providing treatment to people living with HIV, the study shows that ART programs in 2012 were still suboptimal in delivering treatment to every person eligible according to the 2006 WHO treatment guidelines. Changing the HIV treatment eligibility criteria in itself will not be sufficient to reach the 2020 targets; there is an urgent need to improve the effectiveness of ART programs. Our results suggest that HIV testing and ART initiation, rather than ART effectiveness if actually taken, are crucial steps in need of improvement to achieve effective ART programs.
